Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys (Q45387290)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 January 2009

Language	Label	Description	Also known as
English	Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys	scientific article published on 13 January 2009

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys (English)

1 reference

Europe PubMed Central

14 December 2017

influenza A virus

object named as

influenza A virus

1 reference

based on heuristic

inferred from title

author name string

Tong-Ming Fu

1

1 reference

Europe PubMed Central

14 December 2017

Karen M Grimm

2

1 reference

Europe PubMed Central

14 December 2017

Michael P Citron

3

1 reference

Europe PubMed Central

14 December 2017

Daniel C Freed

4

1 reference

Europe PubMed Central

14 December 2017

Jiang Fan

5

1 reference

Europe PubMed Central

14 December 2017

Paul M Keller

6

1 reference

Europe PubMed Central

14 December 2017

John W Shiver

7

1 reference

Europe PubMed Central

14 December 2017

Xiaoping Liang

8

1 reference

Europe PubMed Central

14 December 2017

Joseph G Joyce

9

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

13 January 2009

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

27

1 reference

Europe PubMed Central

14 December 2017

1440-1447

1 reference

Europe PubMed Central

14 December 2017

9

1 reference

Europe PubMed Central

14 December 2017

Prevention and treatment of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Global epidemiology of influenza: past and present.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Viral ion channels: structure and function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Regulation of pH by the M2 protein of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Improved design and intranasal delivery of an M2e-based human influenza A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Unusually high-level expression of a foreign gene (hepatitis B virus core antigen) in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Transformation of yeast

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Purification of the recombinant hepatitis B virus core antigen (rHBcAg) produced in the yeast Saccharomyces cerevisiae and comparative observation of its particles by transmission electron microscopy (TEM) and atomic force microscopy (AFM).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

A simplified method for determination of peptide-protein molar ratios using amino acid analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Puumala (PUU) hantavirus strain differences and insertion positions in the hepatitis B virus core antigen influence B-cell immunogenicity and protective potential of core-derived particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

HBV core particles as a carrier for B cell/T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Purification of recombinant HBc antigen expressed in Escherichia coli and Pichia pastoris: comparison of size-exclusion chromatography and ultracentrifugation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Folding and assembly of hepatitis B virus core protein: a new model proposal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

The crystal structure of the human hepatitis B virus capsid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Antibody response to the M2 protein of influenza A virus expressed in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Vaccine prevention of meningococcal disease, coming soon?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Role of B cells in antigen presentation of the hepatitis B core

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Universal influenza A vaccine: optimization of M2-based constructs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Human T-cell responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.12.034

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45387290&oldid=2076318191"